02.12.2010 • News

EU Clears Ashland, Sud-Chemie Joint Venture

U.S. chemicals company Ashland and Sud-Chemie secured European Union regulatory approval on Tuesday to set up a joint venture in the foundry chemical sector.

The companies said in July they would merge their worldwide foundry chemical activities under the name Ask Chemicals, which will have its headquarters in Hilden, Germany. They expect to close the deal by the end of the year.
The European Commission, the EU competition watchdog, approved the joint venture and said the deal would not hamper competition in the European Economic Area (EEA).

"After examining the operation carefully, the Commission concluded that the transaction would not significantly impede effective competition in the EEA and has therefore approved the concentration," it said in a statement.

Germany's Sud-Chemie is active in speciality chemical products while U.S.-based Ashland is a manufacturer of chemical specialty and performance products as well as a distributor of chemicals and plastics.

Company

Süd-Chemie

Lenbachplatz 6
80333 München
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.